Gilead Sciences on Tuesday named former Roche executive Cindy Perettie as the next head of its cell therapy business Kite Pharma, moving quickly to fill the vacancy left by Christi Shaw, who stepped down from the role at the end of March.
Perettie most recently led Roche’s molecular lab division, and previously was CEO of the Roche-owned cancer diagnostics company Foundation Medicine. She’ll start as executive vice president of Kite on May 30, and join Gilead’s senior leadership team.
